Kara Kimberly Siegrist

Kara Kimberly Siegrist

Auto-generated profile, based on publicly available information

Kara Kimberly Siegrist

Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2023 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
MNMaziar M. Nourian
Maziar M. Nourian
CSCosby A. Stone
Cosby A. Stone
KSKara K. Siegrist
Kara K. Siegrist
Matthias RiessMatthias Riess
Matthias Riess

4 December 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
WWWei Kelly Wu
Wei Kelly Wu
KSKara K. Siegrist
Kara K. Siegrist
IZIoannis A. Ziogas
Ioannis A. Ziogas
KMKelly L. Mishra
Kelly L. Mishra
LMLea K. Matsuoka
Lea K. Matsuoka
SASophoclis Alexopoulos
Sophoclis Alexopoulos

17 August 2020 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
WDWills C. Dunham
Wills C. Dunham
FLFrederick W. Lombard
Frederick W. Lombard
DEDavid A. Edwards
David A. Edwards
YSYaping Shi
Yaping Shi
MSMatthew S. Shotwell
Matthew S. Shotwell
MKMiklos D Kertai
Miklos D Kertai
Background: We examined how intercostal nerve block (ICNB) with standard bupivacaine and ICNB with extended-release liposomal bupivacaine, compared with thoracic epidural analgesia (TEA), were associated with postoperative opioid pain medication consumption and hospital length of stay (LOS) after thoracic surgery. Methods: We studied 1935 patients who underwent thoracic surgery between January 1, 2010, and November 30, 2017, at a tertiary academic center. Primary and secondary outcomes were postoperative opioid consumption expressed as morphine milligram equivalents (MMEs) at 24, 48, and 72 hours after surgery, the LOS, and total MME consumption from surgery to discharge. Results: Of these patients, 888 (45.9%) received TEA, 730 (37.7%) ICNB with standard bupivacaine, 127 (6.6%) ICNB with liposomal bupivacaine, and 190 (9.8%) no regional analgesia. Compared with epidural analgesia, in 2017, ICNB liposomal bupivacaine provided similar pain control in terms of MME consumption at 24 and 72 hours, but decreased MME consumption at 48 hours (odds ratio [OR] = 0.33; confidence interval [CI] = 0.14-0.81) and at discharge (OR = 0.28; CI = 0.12-0.68) and was associated with a higher likelihood for a shorter LOS (hazard ratio = 3.46; CI = 2.42-4.96). Compared with TEA, ICNB with standard bupivacaine and no regional analgesia use showed varying impact on MME consumption between 24 and 72 hours after surgery, and their use was not associated with a significantly reduced MME consumption at discharge but with a shorter hospital LOS. Conclusions: Multimodal analgesia involving regional anesthetic alternatives to TEA could help manage postoperative pain in thoracic surgery patients.

26 March 2025 in Journal of Clinical Anesthesia
Verified
Journal Article
Open access
WCWilliam Chang
William Chang
MXMing-Ray Xu
Ming-Ray Xu
AGAlexander George
Alexander George
MKMeredith Kingeter
Meredith Kingeter
CHChristopher Patrick Henson
Christopher Patrick Henson
KSKara Siegrist
Kara Siegrist
Hyperkalemia commonly occurs in patients undergoing liver transplantation. The intraoperative course of liver transplant often involves hemodynamic and metabolic derangements leading up to liver reperfusion. Potassium levels can rise to dangerous levels immediately after reperfusion. The consequences of intraoperative hyperkalemia include risk of malignant arrhythmias and cardiac arrest. This review explores the numerous causes of hyperkalemia, including contributing surgical and anesthetic factors. The authors also discuss various treatment options and surgical techniques to manage perioperative hyperkalemia. It is important for anesthesiologists to understand the implications and management of hyperkalemia to optimize patients and reduce the risk of an intraoperative cardiac arrest.

26 May 2022 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NSNicholas J. Statzer
Nicholas J. Statzer
APAndreas C. Plackis
Andreas C. Plackis
AWAustin A. Woolard
Austin A. Woolard
BABrian F. S. Allen
Brian F. S. Allen
KSKara K. Siegrist
Kara K. Siegrist
MSMatthew Shotwell
Matthew Shotwell
Background. A retrospective case-control study was conducted to assess the feasibility of erector spinae plane (ESP) block as part of a multimodal enhanced recovery program for patients undergoing minimally invasive mitral valve replacement surgery. Methods. This retrospective analysis was conducted at a single center between January and August 2019. 61 patients were included; 23 received ESP and 38 did not. Erector spinae catheters (ESCs) were placed preoperatively, using a loading dose of 30 mL .5% ropivacaine, followed by an infusion of .2% ropivacaine at 10 mL/h throughout the study period. Primary outcome was 48-hour opioid consumption. Secondary outcomes included intraoperative morphine equivalents, extubation within 24 hours, reintubation, ICU length of stay and hospital length of stay and 30-day mortality. Results. Median [inter-quartile range] of the postoperative morphine milligram equivalents (MMEs) in the first 48 hours was 70[45-121] MMEs in the ESC) group, and 109[70–148] MMEs in the no ESC group ( P-value = .16). No significant difference was observed in intraoperative morphine equivalents, extubation within 24 hours or ICU length of stay. The ESC group had shorter hospital length of stay (6.0 vs 7.0 days, P-value = .043). Conclusion. This study found a statistically insignificant, though potentially clinically significant reduction in postoperative opioid consumption. A reduced hospital length of stay as well as an acceptable safety profile was also observed in the ESC group. An adequately powered, prospective trial is warranted to accurately assess the potential role for ESP catheters for patients undergoing minimally invasive mitral valve surgery.

30 July 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
RLRyan J. Lefevre
Ryan J. Lefevre
GCGeorge H. Crossley
George H. Crossley
LSLaura L. Sorabella
Laura L. Sorabella
KSKara K. Siegrist
Kara K. Siegrist
SESusan S. Eagle
Susan S. Eagle